The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for N Yusuff


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein-protein interactions.EBI
Novartis Institutes For Biomedical Research
1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.EBI
Novartis Institutes For Biomedical Research
Selective deuteration of bupropion slows epimerization and reduces metabolism.EBI
University of Washington
Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.EBI
Novartis Institutes For Biomedical Research
Indole derivatives and their use in neurodegenerative diseasesBDB
Merck Patent
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsBDB
Incyte
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useBDB
Merck Sharp & Dohme
Oxygenation of monoenoic fatty acids by CYP175A1, an orphan cytochrome P450 from Thermus thermophilus HB27.BDB
Tata Institute of Fundamental Research
Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.BDB
Astrazeneca Pharmaceuticals
Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology.BDB
Glaxosmithkline